# GINS1

## Overview
GINS1 is a gene that encodes the GINS complex subunit 1, a crucial component of the GINS complex involved in DNA replication. The GINS complex, comprising GINS1, GINS2, GINS3, and GINS4, forms part of the CDC45-MCM-GINS (CMG) helicase complex, which is essential for the initiation and progression of DNA replication in eukaryotic cells. The GINS1 protein, characterized by its distinct N-terminal and C-terminal domains, plays a pivotal role in stabilizing replication forks and ensuring accurate chromosome replication. It interacts with various proteins, including TopBP1 and Dpb11, to facilitate the assembly of the active replicative helicase. Mutations or deficiencies in GINS1 can lead to impaired DNA replication, resulting in clinical manifestations such as growth retardation and immune deficiencies. Additionally, alterations in GINS1 expression have been implicated in cancer, highlighting its significance in maintaining genomic integrity and normal cell division (Chen2023FOXP1GINS1; Cottineau2017Inherited).

## Structure
The GINS1 protein is a component of the GINS complex, which is essential for DNA replication. It is a heterotetrameric structure that includes GINS1, GINS2, GINS3, and GINS4. The GINS1 protein itself has a distinct molecular structure, featuring an N-terminal alpha helix-rich domain (residues 1-145) and a C-terminal beta strand-rich domain (residues 146-196) (Cottineau2017Inherited). The N-terminal domain is crucial for interactions with other GINS complex components, such as GINS3 and GINS4, while the C-terminal domain may interact with other partners like MCMs, CDC45, or DNA polymerases, although it is not essential for GINS complex formation (Cottineau2017Inherited).

Mutations in GINS1, such as R83C and C152Y, can affect the protein's ability to form the GINS complex, impacting its function in DNA replication (Cottineau2017Inherited). The presence of splice variant isoforms is suggested by the mention of alternatively spliced mRNAs capable of translation re-initiation from different ATG codons (Cottineau2017Inherited). The GINS1 protein is involved in maintaining genomic integrity, and its deficiency can lead to nuclear and cell cycle abnormalities (Cottineau2017Inherited).

## Function
The GINS1 gene encodes a subunit of the GINS complex, which is essential for DNA replication in eukaryotic cells. This complex, composed of GINS1, GINS2, GINS3, and GINS4, is a critical component of the CDC45-MCM-GINS (CMG) helicase complex. The CMG complex is responsible for the initiation and progression of DNA replication by stabilizing replication forks and facilitating the unwinding of DNA strands, which is crucial for accurate chromosome replication (Zhou2022Comprehensive; Cottineau2017Inherited).

GINS1 plays a vital role in the formation and stability of the CMG complex, interacting closely with other subunits to ensure efficient DNA replication. This interaction is crucial for maintaining genomic stability and preventing replication stress, which can lead to DNA damage and genomic instability (Zhou2022Comprehensive; Cottineau2017Inherited). In healthy human cells, GINS1 is active in the nucleus, where it contributes to the regulation of the cell cycle and cell proliferation, ensuring that DNA replication occurs once per cell cycle (Ahmad2024Upregulation; Cottineau2017Inherited).

The proper function of GINS1 is essential for normal cell division and the maintenance of genomic integrity, with deficiencies in GINS1 leading to impaired DNA replication and associated clinical manifestations such as growth retardation and immune deficiencies (Cottineau2017Inherited).

## Clinical Significance
Mutations in the GINS1 gene are associated with a range of clinical conditions, primarily due to its role in DNA replication. Patients with inherited GINS1 deficiency exhibit growth retardation, neutropenia, and NK cell deficiency. These conditions are linked to compound heterozygous mutations in GINS1, which impair the assembly and function of the GINS complex, leading to replication stress and genomic instability (Cottineau2017Inherited). The clinical manifestations include intrauterine and postnatal growth retardation, chronic neutropenia, and susceptibility to infections, as well as potential development of cancer such as osteosarcoma (Cottineau2017Inherited).

Alterations in GINS1 expression are also implicated in cancer. In synovial sarcoma, GINS1 is identified as a downstream target oncogene, with its expression being notably higher in tumor samples. Targeting GINS1 with the drug anlotinib has shown potential in inhibiting tumor growth (Tang2019Anlotinib). In diffuse large B-cell lymphoma (DLBCL), GINS1 expression is upregulated and associated with poor survival outcomes. The FOXP1 transcription factor directly regulates GINS1, contributing to DLBCL proliferation and resistance to chemotherapy, particularly doxorubicin (Chen2023FOXP1GINS1).

## Interactions
GINS1, a component of the GINS complex, plays a critical role in DNA replication through its interactions with various proteins. It is part of the CMG complex, which includes CDC45 and MCM proteins, essential for helicase activity during DNA replication (Hu2022Identification). GINS1 interacts with the TopBP1 protein in vertebrates, specifically between the BRCT3 and BRCT4 regions of TopBP1, which is crucial for efficient DNA replication (Tanaka2013Efficient). This interaction is similar to the interaction observed in Xenopus and is necessary for the stabilization of pre-LC and pre-IC complexes, important for the assembly of the active replicative helicase (Tanaka2013Efficient).

In yeast, GINS1 interacts with Dpb11, a protein that facilitates DNA replication. The interaction between Dpb11 and GINS is stabilized by other components like Pol ε and phosphorylated Sld2, indicating a cell cycle-dependent interaction (Tanaka2013Efficient). The inter-BRCT region of Dpb11, located between BRCT2 and BRCT3, is identified as a GINS interaction domain crucial for cell growth and DNA replication (Tanaka2013Efficient). These interactions highlight the essential role of GINS1 in the initiation and progression of DNA replication.


## References


[1. (Tanaka2013Efficient) Seiji Tanaka, Yayoi Komeda, Toshiko Umemori, Yumiko Kubota, Haruhiko Takisawa, and Hiroyuki Araki. Efficient initiation of dna replication in eukaryotes requires dpb11/topbp1-gins interaction. Molecular and Cellular Biology, 33(13):2614–2622, July 2013. URL: http://dx.doi.org/10.1128/MCB.00431-13, doi:10.1128/mcb.00431-13. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.00431-13)

[2. (Chen2023FOXP1GINS1) Zhenfa Chen, Ting Wang, Cui Li, Wei Zhang, Wenbin Huang, Jun Xue, Jundong Wang, and Shufeng Li. Foxp1-gins1 axis promotes dlbcl proliferation and directs doxorubicin resistance. Journal of Cancer, 14(12):2289–2300, 2023. URL: http://dx.doi.org/10.7150/jca.85906, doi:10.7150/jca.85906. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.85906)

[3. (Hu2022Identification) Changpeng Hu, Yue Dai, Huyue Zhou, Jing Zhang, Dandan Xie, Rufu Xu, Mengmeng Yang, and Rong Zhang. Identification of gins1 as a therapeutic target in the cancer patients infected with covid-19: a bioinformatics and system biology approach. Hereditas, December 2022. URL: http://dx.doi.org/10.1186/s41065-022-00258-5, doi:10.1186/s41065-022-00258-5. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s41065-022-00258-5)

[4. (Ahmad2024Upregulation) M. Ahmad, Y. Hameed, M. Khan, M Usman, A. Rehman, U. Abid, R. Asif, H. Ahmed, M. S. Hussain, J. U. Rehman, H. M. Asif, R. Arshad, M. Atif, A. Hadi, U. Sarfraz, and U. Khurshid. Up-regulation of gins1 highlighted a good diagnostic and prognostic potential of survival in three different subtypes of human cancer. Brazilian Journal of Biology, 2024. URL: http://dx.doi.org/10.1590/1519-6984.250575, doi:10.1590/1519-6984.250575. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1590/1519-6984.250575)

[5. (Zhou2022Comprehensive) Chuqiao Zhou, Zhuoyuan Chen, Bo Xiao, Cheng Xiang, Aoyu Li, Ziyue Zhao, and Hui Li. Comprehensive analysis of gins subunits prognostic value and cerna network in sarcoma. Frontiers in Cell and Developmental Biology, August 2022. URL: http://dx.doi.org/10.3389/fcell.2022.951363, doi:10.3389/fcell.2022.951363. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.951363)

[6. (Tang2019Anlotinib) L. Tang, W. Yu, Y. Wang, H. Li, and Z. Shen. Anlotinib inhibits synovial sarcoma by targeting gins1: a novel downstream target oncogene in progression of synovial sarcoma. Clinical and Translational Oncology, 21(12):1624–1633, April 2019. URL: http://dx.doi.org/10.1007/s12094-019-02090-2, doi:10.1007/s12094-019-02090-2. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12094-019-02090-2)

[7. (Cottineau2017Inherited) Julien Cottineau, Molly C. Kottemann, Francis P. Lach, Young-Hoon Kang, Frédéric Vély, Elissa K. Deenick, Tomi Lazarov, Laure Gineau, Yi Wang, Andrea Farina, Marie Chansel, Lazaro Lorenzo, Christelle Piperoglou, Cindy S. Ma, Patrick Nitschke, Aziz Belkadi, Yuval Itan, Bertrand Boisson, Fabienne Jabot-Hanin, Capucine Picard, Jacinta Bustamante, Céline Eidenschenk, Soraya Boucherit, Nathalie Aladjidi, Didier Lacombe, Pascal Barat, Waseem Qasim, Jane A. Hurst, Andrew J. Pollard, Holm H. Uhlig, Claire Fieschi, Jean Michon, Vladimir P. Bermudez, Laurent Abel, Jean-Pierre de Villartay, Frédéric Geissmann, Stuart G. Tangye, Jerard Hurwitz, Eric Vivier, Jean-Laurent Casanova, Agata Smogorzewska, and Emmanuelle Jouanguy. Inherited gins1 deficiency underlies growth retardation along with neutropenia and nk cell deficiency. Journal of Clinical Investigation, 127(5):1991–2006, April 2017. URL: http://dx.doi.org/10.1172/jci90727, doi:10.1172/jci90727. This article has 116 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci90727)